Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin spot trading volume hits 2019 lows as institutions shift to bonds amid market uncertainty.

Market News
31 Jul 2026
Dailycoin
View Source
Bearish
pluang ai news

Bitcoin's spot trading volume has dropped to levels not seen since 2019, driven by institutional investors moving their funds to cash and government bonds. This shift is influenced by a rare prolonged inversion where Bitcoin's three-month futures yield remains below the U.S. two-year Treasury yield, signaling reduced confidence in Bitcoin's near-term prospects. Despite Bitcoin trading above $63,000, the ongoing mild but uncertain bear market and deep fear sentiment keep investors cautious, with no clear market bottom confirmed yet. This cautious environment suggests continued volatility and careful monitoring by traders.

More News

Lear Corporation beats Q2 2026 earnings and revenue estimates, raises full-year guidance.

Lear Corporation beats Q2 2026 earnings and revenue estimates, raises full-year guidance.

Lear Corporation reported strong Q2 2026 results with earnings per share of $4.28, surpassing analyst estimates of $3.89, and revenue of $6.21 billion, exceeding expectations of $6.14 billion. This marks consistent growth, driven by new business wins...

Company Fundamentals
Bullish
59 minutes ago
Analyst lowers Grand Canyon Education price target to $200 despite strong Q2 earnings beating estimates.

Analyst lowers Grand Canyon Education price target to $200 despite strong Q2 earnings beating estimates.

Grand Canyon Education reported strong Q2 earnings of $1.81 per share, beating estimates of $1.69, with revenues of $264.05 million surpassing expectations. Despite this, an analyst from Barrington lowered the stock price target from $230 to $200, st...

Analyst Insights
Bullish
1 hour ago
Neurocrine Biosciences posts strong Q2 revenue growth and raises 2026 sales guidance.

Neurocrine Biosciences posts strong Q2 revenue growth and raises 2026 sales guidance.

Neurocrine Biosciences reported a 39% increase in Q2 2026 revenues to $959 million and non-GAAP earnings of $2.85 per share, beating estimates. Sales of its key drug INGREZZA rose 15% year-over-year, prompting the company to raise its 2026 sales fore...

Company Fundamentals
Bullish
1 hour ago
WisdomTree beats Q2 earnings and revenue estimates with strong financial health.

WisdomTree beats Q2 earnings and revenue estimates with strong financial health.

WisdomTree reported Q2 earnings per share of $0.31, surpassing analyst estimates of $0.26 and showing significant growth from $0.18 last year. The company also exceeded revenue expectations with $177.16 million, a 57.3% increase year-over-year. This ...

Company Fundamentals
Bullish
2 hours ago
Alpha Compute updates total shares outstanding to 72.8M, correcting market data underreporting

Alpha Compute updates total shares outstanding to 72.8M, correcting market data underreporting

Alpha Compute Corp., a leader in AI GPU-as-a-service and confidential computing, announced a correction to its total shares outstanding, now confirmed at 72,845,260 shares. This update addresses previous underreporting in market data feeds, ensuring ...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App